Despite a growing global consensus, obstacles to reducing net carbon emissions to zero are stark The global disruptions in energy markets and the war in Ukraine have added impetus to the push for ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results